Table 2 Primary clinical endpoint (combination of death, MI and TVR)
At 5 years FU (N = 79) | Years 1–5 (N = 77) | |
|---|---|---|
Primary clinical endpoint, n (%) | 10 (12.6%) | 3 (3,9%) |
Death, n (%) | 5 (6.3%) | 3 (3.9%) |
Cardiovascular (sudden death at 14 days, 9 and 51 months), n (%) | 3 (3.8%) | 1 (1.3%) |
Non-cardiac (cancer at 40 months and 50 months), n (%) | 2 (2.5%) | 2 (2.6%) |
Myocardial infarction, n (%) | 2 (2.5%) | 0 (0%) |
Target vessel revascularization, n (%) | 3 (3.8%) | 0 (0%) |
BRS thrombosis definite/probable, n (%) | 2 (2.5%) | 0 (0%) |